Cornerstone Advisory’s BlackRock Health Sciences Trust BME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.07M Sell
53,874
-5,036
-9% -$208K 0.2% 77
2025
Q4
$2.42M Sell
58,910
-2,295
-4% -$90.6K 0.23% 68
2025
Q3
$2.28M Sell
61,205
-78,190
-56% -$2.84M 0.22% 63
2025
Q2
$5.08M Sell
139,395
-11,144
-7% -$404K 0.55% 42
2025
Q1
$5.51M Sell
150,539
-1,762
-1% -$69.9K 0.64% 38
2024
Q4
$6.12M Buy
152,301
+17,847
+13% +$713K 0.7% 35
2024
Q3
$5.64M Sell
134,454
-1,840
-1% -$76.4K 0.74% 36
2024
Q2
$5.57M Sell
136,294
-2,729
-2% -$109K 0.78% 35
2024
Q1
$5.76M Buy
139,023
+20,279
+17% +$849K 0.82% 34
2023
Q4
$4.8M Buy
118,744
+15,861
+15% +$606K 0.75% 33
2023
Q3
$4.03M Buy
102,883
+14,380
+16% +$572K 0.7% 33
2023
Q2
$3.6M Buy
88,503
+3,243
+4% +$133K 0.63% 33
2023
Q1
$3.57M Buy
85,260
+12,639
+17% +$532K 0.64% 32
2022
Q4
$3.16M Buy
72,621
+9,300
+15% +$395K 0.62% 34
2022
Q3
$2.46M Buy
63,321
+11,791
+23% +$502K 0.55% 38
2022
Q2
$2.19M Buy
51,530
+16,312
+46% +$709K 0.5% 36
2022
Q1
$1.6M Buy
+35,218
New +$1.56M 0.24% 67

Other funds holding BME